Cree (CREE) Shares Downgraded at Kaufman, Wunderlich, Merriman, Caris Following Q3 Report

Wall Street analysts are responding to Q3 results and Q4 guidance from Cree (Nasdaq: CREE) Tuesday night.

Cree shares are down more than 6 percent to around $38.32 in pre-market action.

The following firms downgraded Cree shares:

• Kaufman - from Hold to Sell, price target reduced from $40 to 429
  
• Wunderlich - from Buy to Hold, target cut from $80 to $40
  
• Merriman - from Buy to Neutral
  
• Caris - from Above Average to Average

Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Cree following the earnings report.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Northeast Community Bancorp, Inc. (NECB) Tops Q1 EPS by 12c
• MarineMax (HZO) PT Lowered to $35 at Stifel